Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMNR - Immune Response -- Ignore unavailable to you. Want to Upgrade?

To: Manny Gugliuzza who wrote (1075)	10/1/1998 8:34:00 AM
From: John S. Baker	Read Replies (2) \| Respond to of 1510

Thanks for both sets of resources. The reason I asked is that there seem to be multiple interpretations of the statistical information (and "indicators") within the information provided on various sites. First is clearly, as you have implied, the specific parameters selected for the analysis. In my experience, the "stochastics" indicator seems to be particularly sensitive in this regard -- almost to the extent that one can get pretty much any response he desires merely by adjusting the parameters. It was important for me to be able to recreate your results using your parameters. But another glitch in technical analysis is that different indicators can be more or less useful for different stocks. The site at tscn.com is particularly useful in this regard, as it permits the operator to test sensitivity to several indicators over varying periods of time. Lastly, it is often useful to visually examine each stock's trading record against its indicators. In the case of IMNR, for instance, looking closely at iqc.com shows that trading profits in IMNR would be maximized ... and whiplash greatly reduced ... over the past 9 months by buying/selling when the smoothed stochastic crosses the 20/80 lines (headed in the correct direction), rather that when they cross each other (the classical indicator). And I note that as of yesterday's close, it's not yet time to dump my trading stash ... almost, but not quite. Happy Due Diligence. JSb.